Mc Mackin Stark Zimnoch is categorized under Internal Medicine Doctors in Washington, DC and active since 1993.
Mc Mackin Stark Zimnoch was established in 1993, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Christopher Mcmackin at the company’s single location by writing to 2311 M St Nw # 302, Washington, District of Columbia DC 20037 or by phoning (202) 296-0043. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Mc Mackin Stark Zimnoch |
Contact Person: | Christopher Mcmackin |
Address: | 2311 M St Nw # 302, Washington, District of Columbia 20037 |
Phone Number: | (202) 296-0043 |
Annual Revenue (USD): | $2.500.000 to $4.999.999 |
Founded: | 1993 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Mc Mackin Stark Zimnoch was started in 1993 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Christopher Mcmackin for inquiries that concern Mc Mackin Stark Zimnoch by calling the company number (202) 296-0043, as your correspondence is most welcome. Additionally, the physical location of the single location of Mc Mackin Stark Zimnoch can be found at the coordinates 38.90532,-77.05027 as well as the street address 2311 M St Nw # 302 in Washington, District of Columbia 20037.
For its online presence, you may visit Mc Mackin Stark Zimnoch’s website at and engage with its social media outlets through on Twitter and on Facebook.